Medico Remedies Limited (NSE:MEDICO)

Medico Remedies Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	100.93	82.91	72.42	48.12	25.9
Depreciation & Amortization	29.76	28.6	27.21	22.18	16.5
Other Amortization	0.54	0.2	-	-	-
Loss (Gain) From Sale of Assets	0	-0.03	0.01	0.39	-
Provision & Write-off of Bad Debts	-5.82	6.26	-1.39	0.62	-
Other Operating Activities	-4.02	-0.96	4.91	0.74	10.8
Change in Accounts Receivable	-69.66	-136.13	-55.62	-38.81	-274.3
Change in Inventory	-103.89	33.62	-15.91	-35.57	-145.5
Change in Accounts Payable	32.01	5.26	38.89	17.49	253.5
Change in Other Net Operating Assets	69.06	4.66	11.16	43.46	-
Operating Cash Flow	48.92	24.38	81.67	58.62	-113.1
Operating Cash Flow Growth	100.67%	-70.15%	39.32%	-	-
Capital Expenditures	-31.87	-24.78	-65.92	-59.13	-169.6
Sale of Property, Plant & Equipment	0.04	0.08	0.05	30.1	-
Investment in Securities	-0.85	-3	-0.87	-0.14	-
Other Investing Activities	1.05	0.94	0.71	0.6	-
Investing Cash Flow	-34.6	-26.77	-66.04	-17.56	-169.6
Short-Term Debt Issued	-	-	-	-	101
Long-Term Debt Issued	-	-	-	-	49.5
Total Debt Issued	-	-	-	-	150.5
Long-Term Debt Repaid	-5.2	-4.9	-4.6	-1.5	-
Net Debt Issued (Repaid)	-5.2	-4.9	-4.6	-1.5	150.5
Issuance of Common Stock	-	-	-	-	41.5
Other Financing Activities	-	-	-13.57	-56.21	-9.2
Financing Cash Flow	-5.2	-4.9	-18.17	-57.71	182.8
Net Cash Flow	9.12	-7.29	-2.54	-16.65	-99.9
Free Cash Flow	17.05	-0.4	15.75	-0.51	-282.7
Free Cash Flow Margin	1.13%	-0.03%	1.12%	-0.04%	-23.10%
Free Cash Flow Per Share	0.20	-0.01	0.19	-0.01	-3.41
Cash Interest Paid	-	-	0.53	2.33	9.2
Cash Income Tax Paid	38.02	31.66	24.95	17.95	9.3
Levered Free Cash Flow	-81.71	-12.13	-18.61	-11.65	-163.84
Unlevered Free Cash Flow	-76.37	-8.11	-14.99	-8.48	-158.9
Change in Working Capital	-72.48	-92.6	-21.48	-13.43	-166.3

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.